Kaleido Biosciences Inc (KLDO) Gross Profit Margin starting from the fourth quarter 2021 to fourth quarter 2020, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Kaleido Biosciences Inc   (NASDAQ: KLDO)


Kaleido Biosciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



KLDO Gross Profit Margin (Dec 31 2021)
Q4
(Sep 30 2021)
Q3
(Jun 30 2021)
Q2
(Mar 31 2021)
Q1
(Dec 31 2020)
Q4
Y / Y Revenue Change 102.47 %
Seq. Revenue Change 373.08 %
Revenue In Millions $0.49
Gross Profit Margin 23.17 %
Gross Profit Margin Total Ranking # 3268
Gross Profit In Millions $0.11
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2021 Gross Profit Margin
Kaleido Biosciences Inc achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions recorded in the previous quarter. Revenue increased by 373.08 % Company accomplished below the average Gross Profit Margin with 23.17 %.


Observing fourth quarter 2021 results within Biotechnology & Pharmaceuticals industry 42 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3268.
Learn about Gross Margin
KLDO's Gross Profit Margin fourth quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 497
Overall # 3202

Gross Profit Margin Statistics
High Average Low
23.17 % 23.17 % 23.17 %
(Dec 31 2021)  




Other Gross Profit Margin Profitability Ratios
KLDO's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
KLDO's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for KLDO's Competitors
Gross Profit Margin Profit Margin for Kaleido Biosciences Inc 's Suppliers
Gross Profit Margin Profit Margin for KLDO's Customers

You may also want to know
KLDO's Annual Growth Rates KLDO's Profitability Ratios KLDO's Asset Turnover Ratio KLDO's Dividend Growth
KLDO's Roe KLDO's Valuation Ratios KLDO's Financial Strength Ratios KLDO's Gross Profit Growth
KLDO's Roa KLDO's Inventory Turnover Ratio KLDO's Growth Rates KLDO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2021, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2021 MRQ Gross ProfitDec 31 2021 MRQ Revenue
Protalix Biotherapeutics inc   63.18 %$ 5.401  Millions$ 8.549  Millions
Adaptive Biotechnologies Corporation  62.15 %$ 23.574  Millions$ 37.930  Millions
Repligen Corp  56.01 %$ 104.473  Millions$ 186.521  Millions
Xtant Medical Holdings Inc   55.07 %$ 7.693  Millions$ 13.969  Millions
Nanostring Technologies Inc   52.78 %$ 22.409  Millions$ 42.455  Millions
Champions Oncology Inc   51.44 %$ 6.787  Millions$ 13.193  Millions
Qiagen N v   48.60 %$ 1,450.820  Millions$ 2,985.376  Millions
Enzo Biochem Inc  47.61 %$ 16.208  Millions$ 34.046  Millions
Valneva Se  46.01 %$ 179.386  Millions$ 389.856  Millions
Cellectis S a   45.26 %$ 25.933  Millions$ 57.293  Millions
Polarityte Inc   43.09 %$ 0.449  Millions$ 1.042  Millions
Creative Medical Technology Holdings Inc   41.78 %$ 0.028  Millions$ 0.068  Millions
Twist Bioscience Corporation  35.61 %$ 14.962  Millions$ 42.018  Millions
Elutia Inc   31.21 %$ 3.390  Millions$ 10.861  Millions
Kaleido Biosciences Inc   23.17 %$ 0.114  Millions$ 0.492  Millions
Cannabis Global Inc.  19.94 %$ 0.114  Millions$ 0.570  Millions
Entera Bio Ltd   17.58 %$ 0.029  Millions$ 0.165  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.